| Claude Elias Younes, MD | |
|
1300 Mineral Spring Ave, North Providence, RI 02904-4606 | |
| (401) 726-2777 | |
| (401) 728-0849 |
| Full Name | Claude Elias Younes |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 43 Years |
| Location | 1300 Mineral Spring Ave, North Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861570871 | NPI | - | NPPES |
| CY04408 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 8289 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of Fatima Hospital | North providence, RI | Hospital |
| Entity Name | Claude E Younes Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003062522 PECOS PAC ID: 8820163827 Enrollment ID: O20080826000144 |
News Archive
By turning skin cells into brain neurons, researchers at the Icahn School of Medicine at Mount Sinai have identified that certain tiny molecules aiding in gene expression, known as microRNAs (miRNAs), are under-expressed in the brains of the 14 schizophrenia patients they studied. Their findings, published online today in the journal Cell Reports, show that one of these molecules, a miRNA known as miR-9, is a risk factor that controls the activity of hundreds of genes.
The incidence and severity of both traditional and emerging cardiovascular disease (CVD) risk factors as well as the response to treatment may differ between genders. In this narrative review, several emerging CVD risk factors (i.e. inflammatory and haemostatic markers, endothelial dysfunction, homocysteine, lipid disorders, microalbuminuria/proteinuria, coronary artery calcium score, arterial stiffness, periodontitis, inflammatory bowel syndrome, obstructive sleep apnea, impaired glucose metabolism, metabolic syndrome and non-alcoholic fatty liver disease) are discussed in the context of gender differences.
UT Dallas researchers are recruiting patients for a new study aimed at determining a connection between hearing deficits and the likelihood of falls.
The University of Michigan Medical School will establish a joint institute with the Peking University Health Science Center in a unique effort to promote research that can lead to breakthroughs in pulmonary, cardiovascular and liver diseases.
Uppsala University scientists have developed a new method for measuring the concentration of the messenger substance for cells, cyclic adenosine monophosphate (cAMP), in individual living cells.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Claude Elias Younes, MD 1300 Mineral Spring Ave, North Providence, RI 02904-4606 Ph: (401) 726-2777 | Claude Elias Younes, MD 1300 Mineral Spring Ave, North Providence, RI 02904-4606 Ph: (401) 726-2777 |
News Archive
By turning skin cells into brain neurons, researchers at the Icahn School of Medicine at Mount Sinai have identified that certain tiny molecules aiding in gene expression, known as microRNAs (miRNAs), are under-expressed in the brains of the 14 schizophrenia patients they studied. Their findings, published online today in the journal Cell Reports, show that one of these molecules, a miRNA known as miR-9, is a risk factor that controls the activity of hundreds of genes.
The incidence and severity of both traditional and emerging cardiovascular disease (CVD) risk factors as well as the response to treatment may differ between genders. In this narrative review, several emerging CVD risk factors (i.e. inflammatory and haemostatic markers, endothelial dysfunction, homocysteine, lipid disorders, microalbuminuria/proteinuria, coronary artery calcium score, arterial stiffness, periodontitis, inflammatory bowel syndrome, obstructive sleep apnea, impaired glucose metabolism, metabolic syndrome and non-alcoholic fatty liver disease) are discussed in the context of gender differences.
UT Dallas researchers are recruiting patients for a new study aimed at determining a connection between hearing deficits and the likelihood of falls.
The University of Michigan Medical School will establish a joint institute with the Peking University Health Science Center in a unique effort to promote research that can lead to breakthroughs in pulmonary, cardiovascular and liver diseases.
Uppsala University scientists have developed a new method for measuring the concentration of the messenger substance for cells, cyclic adenosine monophosphate (cAMP), in individual living cells.
› Verified 5 days ago
Joseph A Farina, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 185a High Service Ave, North Providence, RI 02904 Phone: 401-354-6050 Fax: 401-354-6052 | |
Mayumi Shoi Parker, NP Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1637 Mineral Spring Ave Ste 107, North Providence, RI 02904 Phone: 401-354-4400 | |
Naftali Sabo, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 214 High Service Avenue, North Providence, RI 02904 Phone: 401-353-7370 Fax: 401-353-4385 | |
Dr. Denis E Moonan Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1515 Smith St, Suite N, North Providence, RI 02911 Phone: 401-353-0555 Fax: 401-353-7079 | |
Dr. Javid A Calcatti, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1635 Mineral Spring Ave Ste 203, Suite 305, North Providence, RI 02904 Phone: 401-438-1011 | |
Michael M Palatucci, PAC Internal Medicine Medicare: Medicare Enrolled Practice Location: 1637 Mineral Spring Ave, Suite 215, North Providence, RI 02904 Phone: 401-353-7330 Fax: 401-354-4760 | |
Dr. Angelo B Pharmakidis, M.D.,PH.D Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1637 Mineral Spring Ave, Suite 215, North Providence, RI 02904 Phone: 401-353-7330 Fax: 401-354-4760 |